Mutant prevention concentration of four quinolones against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis

被引:0
|
作者
Nakai, Hajime [1 ,2 ]
Sato, Takumi [1 ]
Uno, Takashi [1 ]
Furukawa, Emiko [1 ]
Kawamura, Masato [1 ]
Takahashi, Hiroshi [3 ]
Watanabe, Akira [4 ]
Fujimura, Shigeru [1 ,4 ]
机构
[1] Tohoku Med & Pharmaceut Univ, Div Clin Infect Dis & Chemotherapy, Sendai, Miyagi, Japan
[2] Tohoku Rosai Hosp, Dept Pharm, Sendai, Miyagi, Japan
[3] Saka Gen Hosp, Dept Resp Med, Shiogama, Japan
[4] Tohoku Univ, Res Div Dev Antiinfect Agents, Inst Dev Aging & Canc, Sendai, Miyagi, Japan
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
PS 035
引用
收藏
页码:S82 / S82
页数:1
相关论文
共 50 条
  • [1] Mutant selection window of four quinolone antibiotics against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis
    Nakai, Hajime
    Sato, Takumi
    Uno, Takashi
    Furukawa, Emiko
    Kawamura, Masato
    Takahashi, Hiroshi
    Watanabe, Akira
    Fujimura, Shigeru
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2018, 24 (02) : 83 - 87
  • [2] In Vitro Activity of Delafloxacin Tested against Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
    Flamm, Robert K.
    Rhomberg, Paul R.
    Huband, Michael D.
    Farrell, David J.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (10) : 6381 - 6385
  • [3] Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis
    Blondeau, JM
    Suter, M
    Borsos, S
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 : 25 - 30
  • [4] Activities of faropenem, an oral β-lactam, against recent US isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
    Critchley, IA
    Karlowsky, JA
    Draghi, DC
    Jones, ME
    Thornsberry, C
    Murfitt, K
    Sahm, DF
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (02) : 550 - 555
  • [5] Susceptibility of Canadian isolates of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae to oral antimicrobial agents
    Blondeau, JM
    Vaughan, D
    Laskowski, R
    Borsos, S
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 17 (06) : 457 - 464
  • [6] In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
    Brueggemann, AB
    Doern, GV
    Huynh, HK
    Wingert, EM
    Rhomberg, PR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) : 447 - 449
  • [7] The Activity of Fluoroquinolones and Other Antimicrobial Agents Against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
    Clyde Thornsberry
    P. Ogilvie
    H. P. Holley
    M. L. Hickey
    M. E. Jones
    I. A. Critchley
    D. F. Sahm
    [J]. Drugs, 1999, 58 : 346 - 348
  • [8] The activity of fluoroquinolones and other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
    Thornsberry, C
    Ogilvie, P
    Holley, HP
    Hickey, ML
    Jones, ME
    Critchley, IA
    Sahm, DF
    [J]. DRUGS, 1999, 58 (Suppl 2) : 346 - 348
  • [9] Oral antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates from Japanese children
    Nishi, J
    Yoshinaga, M
    Tokuda, K
    Masuda, K
    Masuda, R
    Kamenosono, A
    Manago, K
    Miyata, K
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (02) : 130 - 135
  • [10] Comparative in vitro activity of cefprozil against respiratory isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis:: results of a multicenter study
    Hasdemir, U
    Gur, D
    Akgun, H
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S139 - S139